Quantitative analysis of nonsteroidal anti-inflammatory drugs in dried blood spot from mountain ultra-trail runners. Contribution of pharmacokinetic models for the interpretation of the results.
dried blood spot
ibuprofen
mountain ultra‐trail
nonsteroidal anti‐inflammatory drugs
pharmacokinetic model
Journal
Drug testing and analysis
ISSN: 1942-7611
Titre abrégé: Drug Test Anal
Pays: England
ID NLM: 101483449
Informations de publication
Date de publication:
15 Aug 2024
15 Aug 2024
Historique:
revised:
02
07
2024
received:
07
04
2024
accepted:
18
07
2024
medline:
16
8
2024
pubmed:
16
8
2024
entrez:
16
8
2024
Statut:
aheadofprint
Résumé
Monitoring of drug use in athletes is of interest both for health and competition-related issues. Considering the advantages of Dried Blood Sampling (low invasiveness, easy sampling, long term storage), we have validated a quantitative LC-MS/HRMS method for the screening of 16 nonsteroidal anti-inflammatory drugs. For all drugs, accuracy and imprecision were within 15% for the 3 levels of quality control and lower than 20% for the lower limit of quantification. Application was performed from samples obtained for Ultra-Trail du Mont-Blanc® 2021 and 2022. A focus on ibuprofen and its metabolites (hydroxyibuprofen, carboxyibuprofen, ibuprofen glucuronide and hydroxyibuprofen glucuronide) was made because the results showed that it was the most detected nonsteroidal anti-inflammatory drug. Further, an interpretation of the ibuprofen concentrations was proposed either from experimental data obtained after an intake of ibuprofen by 10 control subjects, or from a pharmacokinetic modelling and simulations. Depending on the analytical performances of the method, we proposed possible detection windows for ibuprofen in runners. The pharmacokinetic model made it possible to consider two scenarios with and without modification of the total clearance of ibuprofen linked to a modification of the pharmacokinetics of the drugs due to the practice of a long and intense physical activity.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Drug Testing and Analysis published by John Wiley & Sons Ltd.
Références
Didier S, Vauthier J‐C, Gambier N, Renaud P, Chenuel B, Poussel M. Substance use and misuse in a mountain ultramarathon: new insight into ultrarunners population? Res Sports Med. 2017;25(2):244‐251. doi:10.1080/15438627.2017.1282356
Robach P, Trebes G, Buisson C, et al. Prevalence of drug use in ultra‐endurance athletes. Med Sci Sports Exerc. 2024;56(5):828‐838. doi:10.1249/MSS.0000000000003374
Joslin J, Lloyd JB, Kotlyar T, Wojcik SM. NSAID and other analgesic use by endurance runners during training, competition and recovery. S Afr J Sports Med. 2013;25(4):101‐104, 104. doi:10.7196/SAJSM.495
Mashal MS, Bevalot F, Citterio‐Quentin A, et al. Comparative study between direct analysis in whole blood, oral fluid, and declaration of consumption for the prevalence of nonsteroidal anti‐inflammatory drugs and acetaminophen in ultratrail runners. Drug Test Anal. 2023;15(1):97‐103. doi:10.1002/dta.3374
Martínez S, Aguiló A, Moreno C, Lozano L, Tauler P. Use of non‐steroidal anti‐inflammatory drugs among participants in a mountain ultramarathon event. Sports (Basel). 2017;5(1):5. doi:10.3390/sports5010011
Mashal MS, Nalin M, Bevalot F, Sallet P, Guitton J, Machon C. Simultaneous quantification of 19 nonsteroidal anti‐inflammatory drugs in oral fluid by liquid chromatography‐high resolution mass spectrometry: application on ultratrail runner's oral fluid. Drug Test Anal. 2022;14(4):701‐712. doi:10.1002/dta.3216
ITRA Press statement. August 2019. https://itra.run/News/PressRelease Accessed May 22, 2023
Anonymous. “Bioanalytical method validation,” Available at: https://www.ema.europa.eu/en/bioanalytical-method-validation, 2018.
Morse JD, Stanescu I, Atkinson HC, Anderson BJ. Population pharmacokinetic modelling of acetaminophen and ibuprofen: the influence of body composition, formulation and feeding in healthy adult volunteers. Eur J Drug Metab Pharmacokinet. 2022;47(4):497‐507. doi:10.1007/s13318‐022‐00766‐9
Fornasiero A, Savoldelli A, Fruet D, Boccia G, Pellegrini B, Schena F. Physiological intensity profile, exercise load and performance predictors of a 65‐km mountain ultra‐marathon. J Sports Sci. 2018;36(11):1287‐1295. doi:10.1080/02640414.2017.1374707
Wilhelm AJ, den Burger JCG, Swart EL. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin Pharmacokinet. 2014;53(11):961‐973. doi:10.1007/s40262‐014‐0177‐7
Guo C, Yan H, Liu W, Xiang P, Di B, Shen M. Liquid chromatography with tandem mass spectrometric method for determination of 425 drugs and poisons in dried blood spots and application to forensic cases. Forensic Toxicol. 2023;41(2):241‐248. doi:10.1007/s11419‐023‐00659‐9
Ylitalo P. Effect of exercise on pharmacokinetics. Ann Med. 1991;23(3):289‐294. doi:10.3109/07853899109148062
Lenz TL. The effects of high physical activity on pharmacokinetic drug interactions. Expert Opin Drug Metab Toxicol. 2011;7(3):257‐266. doi:10.1517/17425255.2011.553190
Khazaeinia T, Ramsey AA, Tam YK. The effects of exercise on the pharmacokinetics of drugs. J Pharm Pharm Sci. 2000;3(3):292‐302.
van Baak MA. Influence of exercise on the pharmacokinetics of drugs. Clin Pharmacokinet. 1990;19(1):32‐43. doi:10.2165/00003088‐199019010‐00003
Butler JM, Begg EJ. Free drug metabolic clearance in elderly people. Clin Pharmacokinet. 2008;47(5):297‐321. doi:10.2165/00003088‐200847050‐00002
Davies NM. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet. 1998;34(2):101‐154. doi:10.2165/00003088‐199834020‐00002
Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17(6):275‐342. doi:10.1007/s10787‐009‐0016‐x